Annals of Internal Medicine tip sheet for July 1, 2008, issue

June 30, 2008

1. Benefits of Tight Glucose Control Remain Uncertain for Older Diabetics

In a computer modeling study, researchers set out to assess the effects of comorbid illnesses and functional status on the expected benefits of intensive glucose control. They found that in patients aged 60-80 with Type 2 diabetes and intensive glucose control (HbA1C <7 percent), the presence of comorbid illnesses or functional impairment was a more important predictor life expectancy than benefits intensive glucose control. results study imply that challenge for older patients and their physicians is deciding on value pursuing complex regimen




2. U.S. Task Force Reaffirms Screening Recommendations for Bacteria in Urine

The U.S. Preventive Services Task Force (USPSTF) strongly reaffirmed an earlier recommendation supporting doing a urine culture to screen for asymptomatic bacteriuria (no symptoms despite presence of bacteria) in pregnant women at 12 to 16 weeks' gestation or at the first prenatal visit, if later. In 2004 and now in 2008, the USPSTF recommends against routinely screening men and non-pregnant women. In pregnant women, asymptomatic bacteriuria has been associated with low birthweight babies. Then and now, the USPSTF found strong evidence that screening pregnant women with asymptomatic bacteriuria reduces urinary tract infections in mothers and low birthweight in babies. They found adequate evidence that screening non-pregnant adults with asymptomatic bacteriuria does not improve outcomes. Screening has one potential harm: it could lead to the use of antibiotics in people who would have gotten better without treatment, exposing them to possible antibiotic side effects and increasing antibiotic resistance.




3. "Four-Hour Rule" for Treating Pneumonia Has Lessons for Performance Measurement

Since 2002, all U.S. hospitals have had to publicly report their adherence to a controversial performance standard -- that all patients with community-acquired pneumonia (CAP) receive antibiotics within four hours of hospital admission. Since 2006, adherence brought additional hospital payments. The authors of this article detail the evolution of this performance standard -- from the research behind it to the criticism against it. They describe four lessons for future pay-for-performance standards. The authors say that while missteps will happen, they "should not dissuade us from promoting interventions that can improve patient care nor lead us to insist on unattainable levels of evidence before proceeding."
-end-
Annals of Internal Medicine is published by the American College of Physicians. These highlights are not intended to substitute for articles as sources of information. Information in press materials is copyrighted. Annals of Internal Medicine attribution is required.

American College of Physicians

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.